The US Food and Drug Administration (FDA) has approved Click Therapeutics’ CT-132 as the first prescription digital ...

New data from Janssen-Cilag International NV suggest that subcutaneous DARZALEX (daratumumab) quadruplet therapy could offer ...

Oncodesign Services has announced the appointment of Aidan Synnott as its new Chief Executive Officer (CEO). Synnott has more ...

The European Commission has granted marketing authorisation for Leqembi (lecanemab), making it the first therapy in the EU to slow the progression of early Alzheimer’s disease.

Birmingham researchers have received £230k from Cancer Research Horizons to develop a prototype test for monitoring people ...

New UK clinical trials regulations have been signed into law, with a 12-month rollout starting 11 April. The reforms mark the ...

Real-world data from the University of Catania, Italy, suggest that Pepaxti, a treatment for relapsed, refractory multiple myeloma (RRMM), is effective and well tolerated in heavily pretreated ...

A systematic literature review identified 362 records from 67 studies across 10 countries. Results showed romosozumab significantly improved bone mineral density at 12 months in lumbar spine, total ...